SCHEMBL24201007

SCHEMBL24201007

FC1=C(P)CC(c2ccc3nc4n(c3c2)CCC4)=C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 5/20 0.36
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 2/20 0.36
TGFBR1 P36897 1/20 0.34
ACHE P22303 3/20 0.33
BCHE P06276 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
USP2 O75604 1/20 0.33
CYP1A2 P05177 1/20 0.33
CFTR P13569 1/20 0.33
ALOX15 P16050 1/20 0.33
HKDC1 Q2TB90 1/20 0.33
GOPC Q9HD26 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TP53 P04637 5/20 0.33
NPC1 O15118 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21320926 0.70 PIK3CD (0.46) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21320757 0.68 ALDH1A1 (0.46) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL3029049 0.68 SMN1; SMN2 (0.64) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL14006090 0.68 ALDH1A1 (0.46) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21320580 0.68 CYP11B1 (0.47) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21321045 0.68 MAP4K4 (0.40) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21320925 0.65 SMN1; SMN2 (0.39) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21320697 0.65 RAB9A (0.36) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21320773 0.65 PIK3CA (0.45) SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL20017169 0.65 PIK3CA (0.45) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939980-A1 FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB Biopharma SRL (BE) 2022-01-19 EP disclosed